Locally administered steroids have a long history in ophthalmology for the treatment of
inflammatory conditions. Anterior segment conditions tend to be treated with topical steroids …

Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease (GD).
Choice of treatment should be based on the assessment of clinical activity and severity of …

Thyroid eye disease (TED) is a complex disease associated with myriad clinical
presentations, including facial disfigurement, vision loss, and decreased quality of life …

Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease, though
severe forms are rare. Management of GO is often suboptimal, largely because available …

Graves' orbitopathy (GO) is a complex autoimmune disorder of the orbit that causes the eye
to appear disfigured. GO is typically associated with Graves' disease, an inflammatory …

Purpose: To describe a new classification system of thyroid eye disease (TED) based on the
phenotypic features (clinical and radiologic) of the disease. Methods: Clinical features …

Background: Graves' orbitopathy (GO) is the most frequent extrathyroidal manifestation of
the autoimmune Graves' disease. GO significantly impacts quality of life and has a psycho …

Purpose To assess the efficacy and safety of periocular injections of methotrexate versus
triamcinolone in the management of active thyroid-associated orbitopathy. Study design …

Background. Graves' ophthalmopathy (GO) is a complicated autoimmune disease. Various
therapies have been used to manage GO; however the optimum therapy is not clear …

Abstract Graves' disease (GB), also known as Basedow's disease, is the most common
cause of hyperthyroidism, and thyroid orbitopathy (TO) is its most common non-thyroid …